556 related articles for article (PubMed ID: 25716193)
1. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models.
Wang Q; Qian L; Chen SH; Chu CH; Wilson B; Oyarzabal E; Ali S; Robinson B; Rao D; Hong JS
Brain; 2015 May; 138(Pt 5):1247-62. PubMed ID: 25716193
[TBL] [Abstract][Full Text] [Related]
2. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
3. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
[TBL] [Abstract][Full Text] [Related]
8. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
[TBL] [Abstract][Full Text] [Related]
9. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
10. Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases.
Wang Q; Chu CH; Oyarzabal E; Jiang L; Chen SH; Wilson B; Qian L; Hong JS
Glia; 2014 Dec; 62(12):2034-43. PubMed ID: 25043383
[TBL] [Abstract][Full Text] [Related]
11. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
12. Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity.
Zhou Y; Wu J; Sheng R; Li M; Wang Y; Han R; Han F; Chen Z; Qin ZH
Neuroscience; 2018 Nov; 391():140-153. PubMed ID: 30195055
[TBL] [Abstract][Full Text] [Related]
13. Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.
Kumar V; Singh BK; Chauhan AK; Singh D; Patel DK; Singh C
Mol Neurobiol; 2016 Jul; 53(5):2761-2777. PubMed ID: 25764516
[TBL] [Abstract][Full Text] [Related]
14. Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation.
Hou L; Zhang C; Wang K; Liu X; Wang H; Che Y; Sun F; Zhou X; Zhao X; Wang Q
Toxicology; 2017 Apr; 380():1-10. PubMed ID: 28202386
[TBL] [Abstract][Full Text] [Related]
15. Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration.
Song S; Jiang L; Oyarzabal EA; Wilson B; Li Z; Shih YI; Wang Q; Hong JS
Mol Neurobiol; 2019 Apr; 56(4):2653-2669. PubMed ID: 30051353
[TBL] [Abstract][Full Text] [Related]
16. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease.
Wang J; He C; Wu WY; Chen F; Wu YY; Li WZ; Chen HQ; Yin YY
Pharmacol Biochem Behav; 2015 Nov; 138():96-103. PubMed ID: 26394281
[TBL] [Abstract][Full Text] [Related]
17. The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.
Tu D; Gao Y; Yang R; Guan T; Hong JS; Gao HM
J Neuroinflammation; 2019 Dec; 16(1):255. PubMed ID: 31805953
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Chung YC; Kim SR; Jin BK
J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
[TBL] [Abstract][Full Text] [Related]
20. CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease.
Noelker C; Stuckenholz V; Reese JP; Alvarez-Fischer D; Sankowski R; Rausch T; Oertel WH; Hartmann A; van Patten S; Al-Abed Y; Bacher M
Neurodegener Dis; 2013; 12(2):103-10. PubMed ID: 23147695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
